Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionSevenBridge Financial Group, LLC
Latest Disclosed Ownership7,577 shares
Latest Disclosed Value $ 2,620,978
SevenBridge Financial Group, LLC reports 7.62% decrease in ownership of AMGN / Amgen Inc.

On April 23, 2026 - SevenBridge Financial Group, LLC filed a 13F-HR form disclosing ownership of 7,577 shares of Amgen Inc. (CH:AMGN) valued at $2,620,978 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 8,202 shares of Amgen Inc.. This represents a change in shares of -7.62% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-23 2026-03-31 13F AMGEN COM 031162100 7,577 -625 -7.62 2,621 -8.65 0.4097
2026-02-02 2025-12-31 13F AMGEN COM 031162100 8,202 -257 -3.04 2,868 0.84 0.4612
2025-11-13 2025-09-30 13F AMGEN COM 031162100 8,459 -2,689 -24.12 2,845 -10.45 0.4689
2025-09-04 2025-06-30 13F AMGEN COM 031162100 11,148 -2,305 -17.13 3,177 -14.07 0.5601
2025-05-13 2025-03-31 13F AMGEN COM 031162100 13,453 -4,343 -24.40 3,696 -29.99 0.7273
2025-02-12 2024-12-31 13F AMGEN COM 031162100 17,796 -730 -3.94 5,279 -11.44 0.9986
2024-11-12 2024-09-30 13F AMGEN COM 031162100 18,526 1,079 6.18 5,962 3.87 1.1485
2024-08-09 2024-06-30 13F AMGEN COM 031162100 17,447 537 3.18 5,739 9.04 1.2693
2024-05-10 2024-03-31 13F AMGEN COM 031162100 16,910 -291 -1.69 5,264 6.24 1.1926
2024-01-22 2023-12-31 13F AMGEN COM 031162100 17,201 17 0.10 4,954 7.28 1.1703
2023-10-25 2023-09-30 13F AMGEN COM 031162100 17,184 713 4.33 4,618 26.31 1.1935
2023-07-26 2023-06-30 13F AMGEN COM 031162100 16,471 -80 -0.48 3,657 -8.62 0.9442
2023-04-20 2023-03-31 13F AMGEN COM 031162100 16,551 98 0.60 4,001 -7.41 1.1029
2023-01-26 2022-12-31 13F Amgen COM 031162100 16,453 251 1.55 4,321 18.32 1.2635
2022-10-17 2022-09-30 13F AMGEN COM 031162100 16,202 398 2.52 3,652 -5.02 1.2374
2022-07-12 2022-06-30 13F Amgen Equities 031162100 15,804 -296 -1.84 3,845 -1.23 1.5547
2022-04-15 2022-03-31 13F Amgen COM 031162100 16,100 -511 -3.08 3,893 4.17 1.3667
2022-01-20 2021-12-31 13F/A-1 Amgen COM 031162100 16,611 -151 -0.90 3,737 4.85 1.1299
2021-10-14 2021-09-30 13F Amgen Equities 031162100 16,762 -663 -3.80 3,564 -16.08 1.1880
2021-07-26 2021-06-30 13F Amgen Equities 031162100 17,425 262 1.53 4,247 -0.54 1.3846
2021-04-20 2021-03-31 13F Amgen Equities 031162100 17,163 64 0.37 4,270 8.60 1.5536
2021-01-19 2020-12-31 13F Amgen Equities 031162100 17,099 331 1.97 3,932 -7.74 1.5371
2020-10-22 2020-09-30 13F Amgen Equities 031162100 16,768 -13 -0.08 4,262 7.68 1.9398
2020-07-24 2020-06-30 13F Amgen Equities 031162100 16,781 186 1.12 3,958 17.66 1.9658
2020-04-16 2020-03-31 13F Amgen Equities 031162100 16,595 212 1.29 3,364 -14.81 1.9470
2020-01-17 2019-12-31 13F Amgen Equities 031162100 16,383 -237 -1.43 3,949 22.79 1.0317
2019-10-09 2019-09-30 13F Amgen Equities 031162100 16,620 -65 -0.39 3,216 4.59 1.6912
2019-07-15 2019-06-30 13F Amgen Equities 031162100 16,685 160 0.97 3,075 -2.04 1.1015
2019-05-14 2019-03-31 13F Amgen Equities 031162100 16,525 84 0.51 3,139 -1.94 1.1781
2019-02-14 2018-12-31 13F Amgen Equities 031162100 16,441 100 0.61 3,201 -5.49 1.9588
2018-11-14 2018-09-30 13F Amgen Equities 031162100 16,341 169 1.05 3,387 13.47 1.8002
2018-08-14 2018-06-30 13F Amgen Equities 031162100 16,172 4 0.02 2,985 8.31 1.6627
2018-05-11 2018-03-31 13F Amgen Equities 031162100 16,168 378 2.39 2,756 0.36 1.5813
2018-02-16 2017-12-31 13F Amgen Equities 031162100 15,790 53 0.34 2,746 -6.41 1.5188
2017-11-13 2017-09-30 13F Amgen Equities 031162100 15,737 536 3.53 2,934 12.07 1.6811
2017-08-14 2017-06-30 13F Amgen Common Stock 031162100 15,201 206 1.37 2,618 6.86 1.5983
2017-05-15 2017-03-31 13F Amgen CS 031162100 14,995 -919 -5.77 2,450 -6.31 1.6095
2017-02-03 2016-12-31 13F Amgen CS 031162100 15,914 0 0.00 2,615 0.00 1.8990
2016-12-20 2016-09-30 13F/A-1 Amgen CS 031162100 15,914 422 2.72 2,615 10.95 1.9050
2016-11-28 2016-09-30 13F Amgen CS 031162100 15,914 2,615
2016-08-15 2016-06-30 13F Amgen CS 031162100 15,492 15,492 2,357 1.6516
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.